Susquehanna International Group, LLP Roivant Sciences Ltd. Put Options Transaction History

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$9.08 - $11.62 $287,836 - $368,354
31,700 Added 8.0%
428,000 $4.82 Million
Q1 2025

May 14, 2025
BUY
$10.09 - $12.08 $60,540 - $72,480
6,000 Added 1.54%
396,300 $4 Million
Q4 2024

Feb 14, 2025
SELL
$11.16 - $12.71 $1.14 Million - $1.29 Million
-101,800 Reduced 20.69%
390,300 $4.62 Million
Q3 2024

Nov 14, 2024
SELL
$10.17 - $12.5 $811,566 - $997,500
-79,800 Reduced 13.95%
492,100 $5.68 Million
Q2 2024

Aug 15, 2024
SELL
$10.36 - $11.74 $203,056 - $230,104
-19,600 Reduced 3.31%
571,900 $6.04 Million
Q1 2024

May 07, 2024
SELL
$9.87 - $11.8 $2.4 Million - $2.87 Million
-243,000 Reduced 29.12%
591,500 $6.23 Million
Q4 2023

Feb 14, 2024
BUY
$8.38 - $11.58 $5.53 Million - $7.64 Million
659,600 Added 377.13%
834,500 $9.37 Million
Q3 2023

Nov 14, 2023
BUY
$9.76 - $13.19 $843,264 - $1.14 Million
86,400 Added 97.63%
174,900 $2.04 Million
Q2 2023

Aug 11, 2023
BUY
$7.09 - $10.08 $421,146 - $598,752
59,400 Added 204.12%
88,500 $892,000
Q1 2023

May 16, 2023
BUY
$6.92 - $9.98 $58,820 - $84,830
8,500 Added 41.26%
29,100 $214,000
Q4 2022

Feb 14, 2023
SELL
$3.36 - $7.99 $18,816 - $44,744
-5,600 Reduced 21.37%
20,600 $164,000
Q3 2022

Nov 14, 2022
SELL
$0.51 - $4.84 $12,189 - $115,676
-23,900 Reduced 47.7%
26,200 $84,000

Others Institutions Holding ROIV

# of Institutions
362
Shares Held
456M
Call Options Held
8.36M
Put Options Held
760K
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $11.4B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email